Table 1.
Patient characteristics of the MCL2/3 cohort.
| Parameter | n (%) |
|---|---|
| Male | 83 (74) |
| Stage IV | 95 (85) |
| MIPIlow | 60 (54) |
| MIPIintermediate | 28 (25) |
| MIPIhigh | 23 (21) |
| Blastoid variant of MCL | 26 (23) |
| Common variant of MCL | 86 (77) |
| TP53weak | 78 (70) |
| TP53intermediate | 5 (4) |
| TP53strong | 10 (9) |
| TP53not available | 19 (17) |
| MKI67 (0–9%) | 12 (11) |
| MKI67 (10–29%) | 47 (42) |
| MKI67 (30–100%) | 38 (34) |
| MKI67 (not available) | 15 (13) |